Medical materials

Publication
  • ACR •
  • 14 November, 2024 •
  • •

Improvements in Patient-Reported Outcomes After Treatment with SEL-212 in Adults with Refractory Gout: Results from Two Randomized Phase 3 Trials

Vibeke Strand, Puja Khanna, Alan Kivitz, Nana Kragh, Aletta Falk, Rehan Azeem, Hugues Santin-Janin, Herbert Baraf

Available materials

Poster
Publication
  • ACR •
  • 14 November, 2024 •
  • •

Safety and Efficacy of SEL-212 in the US and ex-US Subgroups: Results from the Phase 3 DISSOLVE Studies

Michael Pillinger, Alan Kivitz, Atul Singhal, Anand Patel, Rehan Azeem, Aletta Falk, Bhavisha Desai, Hugues Santin-Janin, Herbert Baraf

Available materials

Poster
Publication
  • ACR •
  • 14 November, 2024 •
  • •

Impact of Anti-drug Antibodies on the Efficacy of SEL-212 in Patients with Chronic Gout Refractory to Conventional Therapy

Puja Khanna, Vibeke Strand, Atul Singhal, Herbert Baraf, Rehan Azeem, Wesley DeHaan, Sheldon Leung, Hugues Santin-Janin, Aletta Falk, Alan Kivitz

Available materials

Poster
Publication
  • ACR •
  • 14 November, 2024 •
  • •

Efficacy and Safety of Emapalumab in Children and Adults with Macrophage Activation Syndrome (MAS) in Still’s disease: Results from a Phase 3 Study and a Pooled Analysis of Two Prospective Trials

Alexei A. Grom, Uwe Ullman, Adnan Mahmood, Josefin Blomkvist, Brian D. Jamieson, Fabrizio De Benedetti

Available materials

Oral Presentation
Sign up for alerts